202 related articles for article (PubMed ID: 26699852)
1. Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I).
Graffigna G; Barello S; Bonanomi A; Lozza E; Hibbard J
BMC Med Inform Decis Mak; 2015 Dec; 15():109. PubMed ID: 26699852
[TBL] [Abstract][Full Text] [Related]
2. Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version.
Maindal HT; Sokolowski I; Vedsted P
BMC Public Health; 2009 Jun; 9():209. PubMed ID: 19563630
[TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of the German version of the Patient Activation Measure (PAM13).
Zill JM; Dwinger S; Kriston L; Rohenkohl A; Härter M; Dirmaier J
BMC Public Health; 2013 Oct; 13():1027. PubMed ID: 24172020
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of the Korean Version of the "Patient Activation Measure 13" (PAM13-K) in Patients With Osteoarthritis.
Ahn YH; Yi CH; Ham OK; Kim BJ
Eval Health Prof; 2015 Jun; 38(2):255-64. PubMed ID: 24986844
[TBL] [Abstract][Full Text] [Related]
5. Measuring patient activation in The Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13).
Rademakers J; Nijman J; van der Hoek L; Heijmans M; Rijken M
BMC Public Health; 2012 Jul; 12():577. PubMed ID: 22849664
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Evaluation of Chronic Patients Using the Persian Version of Patient Activation Measure (PAM).
Zakeri MA; Esmaeili Nadimi A; Bazmandegan G; Zakeri M; Dehghan M
Eval Health Prof; 2023 Jun; 46(2):115-126. PubMed ID: 35506588
[TBL] [Abstract][Full Text] [Related]
7. Is the Patient Activation Measure a valid measure of osteoarthritis self-management attitudes and capabilities? Results of a Rasch analysis.
Eyles JP; Ferreira M; Mills K; Lucas BR; Robbins SR; Williams M; Lee H; Appleton S; Hunter DJ
Health Qual Life Outcomes; 2020 May; 18(1):121. PubMed ID: 32370751
[TBL] [Abstract][Full Text] [Related]
8. Adaptation to European Spanish and psychometric properties of the Patient Activation Measure 13 in patients with chronic diseases.
Moreno-Chico C; González-de Paz L; Monforte-Royo C; Arrighi E; Navarro-Rubio MD; Gallart Fernández-Puebla A
Fam Pract; 2017 Sep; 34(5):627-634. PubMed ID: 28379415
[TBL] [Abstract][Full Text] [Related]
9. Reliability and Validity of the Patient Activation Measure in Kidney Disease: Results of Rasch Analysis.
Lightfoot CJ; Wilkinson TJ; Memory KE; Palmer J; Smith AC
Clin J Am Soc Nephrol; 2021 Jun; 16(6):880-888. PubMed ID: 34117081
[TBL] [Abstract][Full Text] [Related]
10. Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patients.
Brenk-Franz K; Hibbard JH; Herrmann WJ; Freund T; Szecsenyi J; Djalali S; Steurer-Stey C; Sönnichsen A; Tiesler F; Storch M; Schneider N; Gensichen J
PLoS One; 2013; 8(9):e74786. PubMed ID: 24098669
[TBL] [Abstract][Full Text] [Related]
11. The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.
Roesel I; Froehlich D; Joos S; Valentini J; Mauch H; Martus P
Health Qual Life Outcomes; 2024 May; 22(1):39. PubMed ID: 38764032
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Brazilian Version of the Patient Activation Measure 13.
Cunha CM; da Cunha DCPT; Manzato RO; Nepomuceno E; da Silva D; Dantas RAS
J Nurs Meas; 2019 Apr; 27(1):97-113. PubMed ID: 31068494
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Patient Activation Measure (PAM-13) among adults with cardiac conditions in Singapore.
Ngooi BX; Packer TL; Kephart G; Warner G; Koh KW; Wong RC; Lim SP
Qual Life Res; 2017 Apr; 26(4):1071-1080. PubMed ID: 27645458
[TBL] [Abstract][Full Text] [Related]
14. Psychometric assessment of the patient activation measure short form (PAM-13) in rural settings.
Hung M; Carter M; Hayden C; Dzierzon R; Morales J; Snow L; Butler J; Bateman K; Samore M
Qual Life Res; 2013 Apr; 22(3):521-9. PubMed ID: 22466721
[TBL] [Abstract][Full Text] [Related]
15. Cross-cultural adaptation of the stroke action test for Italian--speaking people.
Denti L; Marcomini B; Riva S; Schulz PJ; Caminiti C;
BMC Neurol; 2015 May; 15():76. PubMed ID: 25958369
[TBL] [Abstract][Full Text] [Related]
16. Cross-cultural adaptation, reliability and validity of the Fremantle Knee Awareness Questionnaire in Italian subjects with painful knee osteoarthritis.
Monticone M; Sconza C; Portoghese I; Nishigami T; Wand BM; Sorrentino G; Lemorini G; Respizzi S; Giordano A; Franchignoni F
Health Qual Life Outcomes; 2021 Apr; 19(1):114. PubMed ID: 33827594
[TBL] [Abstract][Full Text] [Related]
17. Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form Patient Activation Measure (PAM-13).
Rademakers J; Maindal HT; Steinsbekk A; Gensichen J; Brenk-Franz K; Hendriks M
BMC Health Serv Res; 2016 Oct; 16(1):570. PubMed ID: 27729079
[TBL] [Abstract][Full Text] [Related]
18. Cross-cultural adaptation and validation of the Italian version of the Hip disability and Osteoarthritis Outcome Score (HOOS).
Torre M; Luzi I; Mirabella F; Del Manso M; Zanoli G; Tucci G; Romanini E
Health Qual Life Outcomes; 2018 Jun; 16(1):115. PubMed ID: 29866107
[TBL] [Abstract][Full Text] [Related]
19. Adaptation and validation of the German Patient Activation Measure for adolescents with chronic conditions in transitional care: PAM
Bomba F; Markwart H; Mühlan H; Menrath I; Ernst G; Thyen U; Schmidt S
Res Nurs Health; 2018 Feb; 41(1):78-87. PubMed ID: 29266283
[TBL] [Abstract][Full Text] [Related]
20. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers.
Hibbard JH; Stockard J; Mahoney ER; Tusler M
Health Serv Res; 2004 Aug; 39(4 Pt 1):1005-26. PubMed ID: 15230939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
